George A. Cunha
Abbott Fund(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Synthesis and biological activity, Cancer Treatment and Pharmacology, Quinazolinone synthesis and applications, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Discovery ofN-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor(2007)184 cited
- → Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors(2005)152 cited
- → Thienopyridine urea inhibitors of KDR kinase(2006)45 cited
- → Isoindolinone ureas: a novel class of KDR kinase inhibitors(2004)32 cited
- → 1,4-Dihydroindeno[1,2-c]pyrazoles with Acetylenic Side Chains as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors with Low Affinity for the hERG Ion Channel(2007)31 cited
- → Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors(2006)22 cited
- → Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases(2006)21 cited
- → 2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization(2009)21 cited
- → 1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors(2006)19 cited
- → Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitors(2007)11 cited